Robertson Stephens Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Robertson Stephens Wealth Management's ADPT Position: Q3 2026 in Review
Robertson Stephens Wealth Management reduced its Adaptive Biotechnologies (ADPT) stake by 7.7% in Q3 2026, selling an estimated $184K and leaving 89,718 shares worth $2.59M. The position accounts for 0.06% of the portfolio, ranked #184.
Robertson Stephens Wealth Management first reported a position in ADPT in Q4 2019 and has held it in 28 quarters since. The position peaked at $23.2M in Q2 2020. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Robertson Stephens Wealth Management held 89,718 shares of Adaptive Biotechnologies worth $2.59M as of Q3 2026.
- Robertson Stephens Wealth Management sold 7,500 Adaptive Biotechnologies shares in Q3 2026, an estimated $184K.
- Adaptive Biotechnologies made up 0.06% of Robertson Stephens Wealth Management's portfolio in Q3 2026, its #184 holding.
- Robertson Stephens Wealth Management first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 28 quarters since.
- Robertson Stephens Wealth Management's Adaptive Biotechnologies position peaked at $23.2M in Q2 2020.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Robertson Stephens Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.